These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11777207)

  • 1. Immune responses and immunity in hepatitis C virus infection.
    Mizukoshi E; Rehermann B
    J Gastroenterol; 2001 Dec; 36(12):799-808. PubMed ID: 11777207
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune responses in hepatitis C virus infection: the role of dendritic cells.
    Fowler NL; Torresi J; Jackson DC; Brown LE; Gowans EJ
    Immunol Cell Biol; 2003 Feb; 81(1):63-6. PubMed ID: 12534948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunity against hepatitis C virus infection.
    Elliot LN; Lloyd AR; Ziegler JB; Ffrench RA
    Immunol Cell Biol; 2006 Jun; 84(3):239-49. PubMed ID: 16509830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for a vaccine against the hepatitis C virus.
    Houghton M; Abrignani S
    Nature; 2005 Aug; 436(7053):961-6. PubMed ID: 16107836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune and non-immune responses to hepatitis C virus infection.
    Sun J; Rajsbaum R; Yi M
    World J Gastroenterol; 2015 Oct; 21(38):10739-48. PubMed ID: 26478666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design.
    Freeman ZT; Cox AL
    PLoS Pathog; 2016 Jun; 12(6):e1005632. PubMed ID: 27362419
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunology of hepatitis B virus and hepatitis C virus infection.
    Rehermann B; Nascimbeni M
    Nat Rev Immunol; 2005 Mar; 5(3):215-29. PubMed ID: 15738952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-viral immune responses against hepatitis C virus].
    Imawari M
    Uirusu; 2002 Jun; 52(1):151-6. PubMed ID: 12227166
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccines: a moving target.
    Eisenstein M
    Nature; 2011 Jun; 474(7350):S16-7. PubMed ID: 21666730
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA vaccines for hepatitis C virus.
    Brinster C; Inchauspé G
    Intervirology; 2001; 44(2-3):143-53. PubMed ID: 11509875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.
    Capone S; Meola A; Ercole BB; Vitelli A; Pezzanera M; Ruggeri L; Davies ME; Tafi R; Santini C; Luzzago A; Fu TM; Bett A; Colloca S; Cortese R; Nicosia A; Folgori A
    J Virol; 2006 Feb; 80(4):1688-99. PubMed ID: 16439526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus: models of immunopathogenesis and prophylaxis.
    Eckels DD; Flomenberg P; Gill JC
    Transfusion; 1996 Sep; 36(9):836-44. PubMed ID: 8823462
    [No Abstract]   [Full Text] [Related]  

  • 13. The challenge of developing a vaccine against hepatitis C virus.
    Forns X; Bukh J; Purcell RH
    J Hepatol; 2002 Nov; 37(5):684-95. PubMed ID: 12399239
    [No Abstract]   [Full Text] [Related]  

  • 14. Current progress in host innate and adaptive immunity against hepatitis C virus infection.
    Shi J; Li Y; Chang W; Zhang X; Wang FS
    Hepatol Int; 2017 Jul; 11(4):374-383. PubMed ID: 28643186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
    Torresi J; Johnson D; Wedemeyer H
    J Hepatol; 2011 Jun; 54(6):1273-85. PubMed ID: 21236312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.
    Singh S; Vedi S; Samrat SK; Li W; Kumar R; Agrawal B
    PLoS One; 2016; 11(1):e0146404. PubMed ID: 26751211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies.
    Lauer GM
    J Infect Dis; 2013 Mar; 207 Suppl 1():S7-S12. PubMed ID: 23390305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immune responses against persistent hepatitis C virus: gone but not forgotten.
    Klenerman P; Semmo N
    Gut; 2006 Jul; 55(7):914-6. PubMed ID: 16766748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection and defence mechanisms in HCV infection.
    Inchauspé G
    Nephrol Dial Transplant; 1996; 11 Suppl 4():6-8. PubMed ID: 8918742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C virus and immune response].
    Pawlotsky JM
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B123-33. PubMed ID: 11449153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.